OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001145460

ALERE INC.

ALERE INC. (CIK 0001145460, EIN 04-3565120) reported revenue of $2.38 billion ($2,376,335,000) for FY2016 (2016-01-01 to 2016-12-31) and net income of -$137.62 million (-$137,619,000) for FY2016 (2016-01-01 to 2016-12-31), as filed in its 10-K filed 2017-06-05 (accession 0001193125-17-194626).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001145460
EIN04-3565120
SIC industry code2835 In Vitro & In Vivo Diagnostic Substances
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryLarge accelerated filer
Entity typeoperating
Olympus entity IDorg_44qyw9csstr5dbzv17z42358ma
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$2,376,335,000FY20162016-01-01 to 2016-12-3110-K2017-06-050001193125-17-194626Revenues
Net income-$137,619,000FY20162016-01-01 to 2016-12-3110-K2017-06-050001193125-17-194626NetIncomeLoss
Total assets$5,648,279,000FY2016as of 2016-12-3110-K2017-06-050001193125-17-194626Assets
Stockholders' equity$1,826,992,000FY2016as of 2016-12-3110-K2017-06-050001193125-17-194626StockholdersEquity
Operating cash flow$179,290,000FY20162016-01-01 to 2016-12-3110-K2017-06-050001193125-17-194626NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$1.83 per shareFY20162016-01-01 to 2016-12-3110-K2017-06-050001193125-17-194626EarningsPerShareBasicAndDiluted
Shares outstanding87,368,721 sharesFY2016as of 2017-05-3110-K2017-06-050001193125-17-194626EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2007-2016, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20162016-01-01 to 2016-12-31$2,376,335,00010-K2017-06-050001193125-17-194626
RevenueFY20152015-01-01 to 2015-12-31$2,455,615,00010-K2017-06-050001193125-17-194626
RevenueFY20142014-01-01 to 2014-12-31$2,577,001,00010-K2017-06-050001193125-17-194626
RevenueFY20132013-01-01 to 2013-12-31$2,608,636,00010-K2016-08-080001193125-16-674184
RevenueFY20122012-01-01 to 2012-12-31$2,394,371,00010-K/A2015-05-280001193125-15-204100
RevenueFY20112011-01-01 to 2011-12-31$2,386,527,00010-K2014-03-030001193125-14-080002
RevenueFY20102009-12-31 to 2010-12-31$2,155,347,00010-K2013-03-010001193125-13-085897
Net incomeFY20162016-01-01 to 2016-12-31-$137,619,00010-K2017-06-050001193125-17-194626
Net incomeFY20152015-01-01 to 2015-12-31$203,684,00010-K2017-06-050001193125-17-194626
Net incomeFY20142014-01-01 to 2014-12-31-$33,153,00010-K2017-06-050001193125-17-194626
Net incomeFY20132013-01-01 to 2013-12-31-$74,958,00010-K2016-08-080001193125-16-674184
Net incomeFY20122012-01-01 to 2012-12-31-$78,492,00010-K/A2015-05-280001193125-15-204100
Net incomeFY20112011-01-01 to 2011-12-31-$133,542,00010-K2014-03-030001193125-14-080002
Net incomeFY20102009-12-31 to 2010-12-31-$1,017,310,00010-K2013-03-010001193125-13-085897
  • Revenue for FY2015 was restated: first reported as $2,463,316,000 (accession 0001193125-16-674184, filed 2016-08-08).
  • Revenue for FY2014 was restated: first reported as $2,586,690,000 (accession 0001193125-15-078928, filed 2015-03-05).
  • Revenue for FY2013 was restated: first reported as $3,029,442,000 (accession 0001193125-14-080002, filed 2014-03-03).
  • Revenue for FY2012 was restated: first reported as $2,818,825,000 (accession 0001193125-13-085897, filed 2013-03-01).
  • Net income for FY2015 was restated: first reported as $206,376,000 (accession 0001193125-16-674184, filed 2016-08-08).
  • Net income for FY2014 was restated: first reported as $9,918,000 (accession 0001193125-15-078928, filed 2015-03-05).
  • Net income for FY2013 was restated: first reported as -$71,254,000 (accession 0001193125-14-080002, filed 2014-03-03).
  • Net income for FY2012 was restated: first reported as -$78,182,000 (accession 0001193125-13-085897, filed 2013-03-01).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2017-08-032017-06-300001193125-17-246690d418991d10q.htm
10-Q2017-06-142017-03-310001193125-17-203491d374871d10q.htm
10-K2017-06-052016-12-310001193125-17-194626d248572d10k.htm
10-Q2016-11-042016-09-300001193125-16-759676d269915d10q.htm
10-Q2016-09-062016-06-300001193125-16-701058d240144d10q.htm
10-Q2016-08-172016-03-310001193125-16-683343d127248d10q.htm
10-K2016-08-082015-12-310001193125-16-674184d78820d10k.htm
10-K/A2015-11-132014-12-310001193125-15-377207d78896d10ka.htm
10-Q2015-11-092015-09-300001193125-15-372187d30877d10q.htm
10-Q2015-08-062015-06-300001193125-15-281293d948683d10q.htm
10-Q2015-05-282015-03-310001193125-15-204131d903329d10q.htm
10-K/A2015-05-282014-12-310001193125-15-204100d920739d10ka.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001145460published by the sourcedata.sec.gov/submissions/CIK0001145460.json2026-10-21
Employer Identification Number (EIN) · US-EIN04-3565120published by the sourcedata.sec.gov/submissions/CIK0001145460.json2026-10-21

Former names

NameFromTo
INVERNESS MEDICAL INNOVATIONS INC2001-10-192010-07-09

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001145460.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001145460.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001145460" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001145460/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001145460/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1145460"}

On SEC EDGAR

About this data